Results 1 to 10 of about 21,193 (165)
Invasive Evaluation for Coronary Vasospasm. [PDF]
US Cardiol, 2023 Vasospastic angina (VSA) occurs at rest and on exertion, with transient electrocardiographic ischemic changes. VSA presents with spontaneous coronary artery spasm (CAS); it has been associated with stable angina, acute coronary syndromes, and sudden cardiac death. CAS can be identified in normal arteries or non-obstructive coronary atherosclerosis, but
Huang J +4 more
europepmc +4 more sources
JACC: Case Reports, 2021 [Figure: see text]
Tabitha G. Moe, Michael P. Savage
openaire +4 more sources
Coronary vasospasm: A narrative review
World Journal of Cardiology, 2021 Coronary artery vasospasm (CAVS) plays an important role in acute chest pain syndrome caused by transient and partial or complete occlusion of the coronary arteries. Pathophysiology of the disease remains incompletely understood, with autonomic and endothelial dysfunction thought to play an important role.
Khagendra Dahal +2 more
openaire +3 more sources
High incidence of Angina pectoris in patients treated with 5-fluorouracil - A planned surveillance study with 102 patients [PDF]
, 2003 Objective: Angina pectoris, arrhythmic sudden death and myocardial infarction, all these cardiac events have occasionally been reported during 5-fluorouracil (5-FU) chemotherapy.
Lersch, C. +4 more
core +1 more source
Coronary Artery Vasospasm [PDF]
Korean Circulation Journal, 2018 Coronary artery vasospasm (CVS) is an important mechanism of myocardial ischemia and produces any of the manifestations of coronary artery disease from silent myocardial ischemia, to effort-induced angina and variant angina, to acute coronary syndrome including myocardial infarction or sudden cardiac death.
openaire +3 more sources
Capecitabine-Induced Coronary Vasospasm [PDF]
Case Reports in Oncology, 2016 Capecitabine, an oral prodrug of 5-fluorouracil (5-FU), is approved for early-stage and advanced colorectal cancer and metastatic breast cancer. Cardiotoxicity of 5-FU is well described in the literature. However, cardiac adverse effects of capecitabine are poorly described. We report a case of coronary vasospasm induced by capecitabine.
Danish Henry +3 more
openaire +3 more sources
A case of repetitive myocardial infarction with unobstructed coronaries due to Churg-Strauss syndrome [PDF]
, 2019 © The Author(s) 2019. Published by Oxford University Press on behalf of the European Society of Cardiology.BackgroundMyocardial infarction is most commonly caused by thrombosis occurring on a background of coronary atherosclerosis, resulting in reduced ...
Agewall +11 more
core +2 more sources
Successful brachytherapy of coronary vasospasm [PDF]
Heart, 2003 Brachytherapy is a proposed treatment for in-stent restenosis and is the subject of several clinical trials and debates. The standard treatment of patients with variant angina is to eliminate vasoconstrictive factors and to administer vasodilating drugs. This is the first description of successful brachytherapy for coronary spasm.
T Chatterjee +3 more
openaire +3 more sources
Vascular complications of cancer chemotherapy [PDF]
, 2015 Development of new anticancer drugs has resulted in improved mortality rates and 5-year survival rates in patients with cancer. However, many of the modern chemotherapies are associated with cardiovascular toxicities that increase cardiovascular risk in ...
Cameron, Alan C. +2 more
core +1 more source
Causes of prehospital misinterpretations of ST elevation myocardial infarction [PDF]
, 2016 Objectives: To determine the causes of software misinterpretation of ST elevation myocardial infarction (STEMI) compared to clinically identified STEMI to identify opportunities to improve prehospital STEMI identification.
Bosson, Nichole +11 more
core +1 more source